Atlas Trials

Bioequivalence

170 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Bioequivalence

RecordFirmDate
A Bioequivalence Study Between Two Brands of Medications to Treat Cough & Cold Symptoms (NCT03213353)Johnson & Johnson Consumer and Personal Products Worldwide2017-07-03
Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition (NCT03232710)Chengdu Kanghong Pharmaceutical Group Co., Ltd.2017-06-26
Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions (NCT03452306)Geropharm2017-06-15
Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg Neulasta (NCT03146988)Gedeon Richter Plc.2017-04-10
Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects (NCT03458208)Geropharm2017-02-14
Bioequivalence Study of Amlodipine and Norvasc Under Fasting and FED Conditions in Chinese Healthy Volunteers (NCT02974439)Shanghai Haini Pharmaceutical Co., Ltd.2016-12-23
Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects (NCT03273088)AryoGen Pharmed Co.2016-12-04
Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteeers (NCT02341274)Indiana University2016-11-11
A Study Of CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects (NCT03273192)Cinnagen2016-10-22
Ibuprofen Bioavailability Trial With Oral Single Dose Administration. (NCT03018015)SocraTec R&D GmbH2016-09-01
Bioequivalence Study of Idalopirdine in Healthy Subjects (NCT02894515)H. Lundbeck A/S2016-09-01
Characterisation of Relative Bioavailability With Bioequivalence Assessment of Deferiprone Tablets After Oral Single Dose Administration (NCT02980458)SocraTec R&D GmbH2016-08-01
A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects (NCT02637037)AstraZeneca2015-12-21
Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese Subjects (NCT02436577)AstraZeneca2015-06-01
Comparison of the Pharmacokinetic and Pharmacodynamic Biosimilarity of CHS-1701 (Coherus Pegfilgrastim) With Neulasta® (Pegfilgrastim) (NCT02385851)Coherus Oncology, Inc.2015-02-01
Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants (NCT02221180)Janssen Research & Development, LLC2014-08-01
Comparison of Two Formulations of Androxal (NCT01984398)Repros Therapeutics Inc.2013-12-31
Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg (NCT02206295)Actelion2012-09-01
Clinical Study to Evaluate the Role of Microdialysis for the Comparison of Topical Products (NCT01592019)University of Florida2012-04-01
A Bioequivalence Study to Compare VIMOVO Manufactured at AstraZenca AB to VIMOVO Manufactured by Patheon Pharmaceuticals and Marketed Enteric-coated Naproxen Formulation (NCT01331993)AstraZeneca2011-09-01
Bio-equivalence Study (NCT01638143)Maastricht University Medical Center2010-11-01
A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers. (NCT01260805)Pfizer2010-09-01
Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine (NCT01094847)Daewoong Pharmaceutical Co. LTD.2010-04-01
Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women (NCT02592031)Merckle GmbH2009-02-01
Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex (NCT04008979)PLx Pharma2008-02-11
A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System (NCT00614029)Zogenix, Inc.2006-12-01
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions (NCT01340625)Teva Pharmaceuticals USA2006-12-01
← Previous

Track Bioequivalence automatically

Every clearance here is in the API, with alerts when new ones post.